Today’s Research Reports on Trending Tickers: Novavax and Sarepta Therapeutics
After posting its first weekly loss in two months on Friday, the Dow Jones and S&P 500 Index opened the week in the green on Monday. The Dow Jones Industrial Average gained 0.07 percent to close at 23,439.70, while the S&P 500 Index rose 0.10 percent to close at 2,584.84. The Nasdaq Composite Index increased 0.10 percent to close at 6,757.60. Major indexes were pressured Monday as shares of General Electric fell to its lowest in five years and worries about tax reform continued to grow. The Senate recently unveiled their own tax reform bill, which had some major differences from the House bill.
RDI Initiates Coverage on:
Sarepta Therapeutics, Inc.
Novavax, Inc.’s stock jumped 8.93% Monday, to close the day at $1.22. The stock recorded a trading volume of 9,925,024 shares, which was above its three months average volume of 3,978,565 shares. In the last year Novavax, Inc.’s shares have traded in a range of 0.73 – 1.78. The share price has gained 67.12% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $1.12 is greater than its 200-day moving average of $1.08. Shares of Novavax have gained roughly 7.02 percent in the past month and are down 3.17 percent year-to-date.
Access RDI’s Novavax, Inc. Research Report at:
On Monday, shares in Sarepta Therapeutics, Inc. recorded a trading volume of 1,630,000 shares, which was below the three months average volume of 2,239,207 shares. The stock ended the day 0.61% higher at 54.49. The share price has gained 107.50% from its 52 week low with a 52 week trading range of 26.26 – 57.57.The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $50.12 is greater than its 200-day moving average of $40.07. Shares of Sarepta Therapeutics have gained roughly 7.75 percent in the past month and are up 98.65 percent year-to-date.
Access RDI’s Sarepta Therapeutics, Inc. Research Report at:
Our Actionable Research on Novavax, Inc. (NASDAQ:NVAX) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.